Optimal Treatment Protocol for Selective Laser Trabeculoplasty (OSLT)
Sponsor: Göteborg University
A NA clinical study on Glaucoma, Open-Angle and Ocular Hypertension, this trial is ongoing. The trial is conducted by Göteborg University and has accumulated 12 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Nov 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2025 — Nov 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Apr 2023 — Jun 2024 [monthly]
Active Not Recruiting NA
-
May 2022 — Apr 2023 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Feb 2022 — May 2022 [monthly]
Enrolling By Invitation NA
-
Feb 2021 — Feb 2022 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation NA
-
Feb 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
Feb 2019 — Feb 2020 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Göteborg University
- Vastra Gotaland Region
For direct contact, visit the study record on ClinicalTrials.gov .